Frontiers in Biostatistics Seminar Tuesday September 15, 2020 at 1:00PM Eastern Time Peter F. Thall, PhD Department of Biostatistics University of Texas M.D. Anderson Cancer Center Abstract: Conventional evaluation of a new drug, 𝐴, is done in three phases. Phase I relies on toxicity to determine a “maximum tolerable dose” (MTD) of 𝐴, in phase […]
Data Science Seminar September 22, 2020 2:00PM ET Ignaty Leshchiner, PhD Postdoctoral Fellow, Harvard Medical School/Brigham and Women's Hospital Zoom link: http://bit.ly/DSSept22 Abstract: Real-time study of tumor emergence and progression in patients will help predict and ultimately change the course of the patient's disease. This could be achieved by inferring genotypes of heterogeneous cell populations within […]
Data Science Seminar September 29, 2020 1:00PM ET Martin Aryee, PhD Assistant Professor of Pathology, Harvard Medical School Assistant Molecular Pathologist, Massachusetts General Hospital Zoom link: https://dfci.zoom.us/j/95524743149?pwd=SzN4cjJZUnhsNVl3dXNmZjZ1N3F4QT09 Abstract: The spatial organization of biological systems can impart additional functionality beyond that of the individual components. This is true at a range of scales – from cells […]
